Trace Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Trace Wealth Advisors's BMY Position: Q1 2026 in Review
Trace Wealth Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 6,000 shares worth $364K. The position accounts for 0.27% of the portfolio, ranked #48.
Trace Wealth Advisors first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $448K in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Trace Wealth Advisors held 6,000 shares of Bristol-Myers Squibb worth $364K as of Q1 2026.
- Trace Wealth Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.27% of Trace Wealth Advisors's portfolio in Q1 2026, its #48 holding.
- Trace Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
- Trace Wealth Advisors's Bristol-Myers Squibb position peaked at $448K in Q1 2025.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Trace Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.